Nitrogen, oxygen or sulfur containing heterocyclic compounds as analgesic drugs used as modulators of the nitroxidative stress

Mini-Reviews in Medicinal Chemistry

Volumn 13, Issue 3, 2013, Pages 335-352

  Sałat, Kinga ^a   Moniczewski, Andrzej ^a   Librowski, Tadeusz ^a  

^a JAGIELLONIAN UNIVERSITY   (Poland)

Author keywords

Analgesic drugs; Enzymatic and non enzymatic antioxidant defense; Free radical species; Heterocycles; Nitroxidative stress

Indexed keywords

ANALGESIC AGENT; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ANTIMIGRAINE AGENT; BUTYROLACTONE; CARBAMAZEPINE; DESIPRAMINE; DULOXETINE; ESCITALOPRAM; FLUOXETINE; GAMMA BUTYROLACTONE; HETEROCYCLIC COMPOUND; INDOMETACIN; MELOXICAM; NITROGEN; OPIATE; OXYGEN RADICAL; PAROXETINE; PEROXIDASE; PEROXYNITRITE; PHENYTOIN; REACTIVE OXYGEN METABOLITE; SCAVENGER; SULFUR; SUPEROXIDE DISMUTASE; TENOXICAM; THIOCTIC ACID; UNINDEXED DRUG; VALDECOXIB;

AGRANULOCYTOSIS; ANALGESIA; ANTINOCICEPTION; ANTIOXIDANT ACTIVITY; APLASTIC ANEMIA; ARTICLE; GASTROINTESTINAL TOXICITY; HEMATOLOGIC DISEASE; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERALGESIA; LIVER FAILURE; MIGRAINE; NEUTROPENIA; NITROXIDATIVE STRESS; OXIDATIVE STRESS;

EID: 84876863811     PISSN: 13895575     EISSN: 18755607     Source Type: Journal    
DOI: 10.2174/138955713804999801     Document Type: Article

References (170)

1. Halliwell, B. Biochemistry of oxidative stress. Biochem. Soc. Trans. 2007, 35, 1147-1150.
2. Genestra, M. Oxyl radicals, redox-sensitive signaling cascades and antioxidants. Cell. Signal., 2007, 19, 1807-1819.
3. Trachootham, D.; Lu, W.; Ogasawara, MA.; Nilsa, R.D.; Huang, P. Redox regulation of cell survival. Antioxid. Redox Signal., 2008, 10, 1343-1374.
4. Valko, M.; Izakovic, M.; Mazur, M.; Rhodes, C.J.; Telser, J. Role of oxygen radicals in DNA damage and cancer incidence. Mol. Cell. Biochem., 2004, 266, 37-56.
5. Valko, M.; Leibfritz, D.; Moncola, J.; Cronin, M.D.;et al. Free radicals and antioxidants in normal physiological functions and human disease. Int. J. Biochem. Cell. Biol., 2007, 39, 44-84.
6. Roberts, R.A.; Smith, R.A.; Safe, S.; Szabo, C.; Tjalkens, R.B.; Robertson, F.M. Toxicological and pathophysiological roles of reactive oxygen and nitrogen species. Toxicology, 2010, 276, 85-94.
7. Salvemini, D.; Little, J.W.; Doyle, T.; Neumann, W.L. Roles of reactive oxygen and nitrogen species in pain. Free Radic. Biol. Med., 2011, 51, 951-966.
8. Izyumov, D.S.; Domnina, L.V.; Nepryakhina, O.K.; Avetisyan, A.V.; Golyshev, S.A.; Ivanova, O.Y.; Korotetskaya, M.V.; Lyamzaev, K.G.; Pletjushkina, O.Y.; Popova, E.N.; Chernyak, B.V. Mitochondria as source of reactive oxygen species under oxidative stress. Study with novel mitochondria-targeted antioxidants-the Skulachev-ion derivatives. Biochemistry (Mosc)., 2010, 75, 123-129.
9. Fato, R.; Bergamini, C.; Leoni, S.; Strocchi, P.; Lenaz, G. Generation of reactive oxygen species by mitochondrial complex I: implications in neurodegeneration. Neurochem. Res., 2008, 33, 2487-2501.
10. Chen, Q.; Vazquez, E.J.; Moghaddas, S.; Hoppel, C.L.; Lesnefsky, E.J. Production of reactive oxygen species by mitochondria: central role of complex III. J. Biol. Chem., 2003, 278, 36027-36031.
11. Hirst, J.; King, M.S.; Pryde, K.R. The production of reactive oxygen species by complex I. Biochem. Soc. Trans., 2008, 36, 976-980.
12. Berrisford, J.M.; Sazanov, L.A. Structural basis for the mechanism of respiratory complex I. J. Biol. Chem., 2009, 284, 29773-29783.
13. Kovacic, P.; Pozos, R.S.; Somanathan, R.; Shangari, N.; O'Brien, P.J. Mechanism of mitochondrial uncouplers, inhibitors, and toxins: Focus on electron transfer, free radicals, and structure-activity relationships. Curr. Med. Chem., 2005, 12, 2601-2623.
14. Starkov, A.A.; Fiskum, G.; Chinopoulos, C.; Lorenzo, B.J.; Browne, S.E.; Patel, M.S.; Beal, M.F. Mitochondrial alpha-ketoglutarate dehydrogenase complex generates reactive oxygen species. J. Neurosci., 2004, 24, 7779-7788.
15. Tretter, L.; Takacs, K.; Hegedus, V.; Adam-Vizi, V. Characteristics of alpha-glycerophosphate-evoked H2O2 generation in brain mitochondria. J. Neurochem., 2007, 100, 650-663.
16. Halliwell, B.; Zhao, K.; Whiteman, M. Nitric oxide and peroxynitrite. The ugly, the uglier and the not so good: a personal view of recent controversies. Free Radic. Res., 1999, 31, 651-669.
17. Ibi, M.; Matsuno, K.; Shiba, D.; Katsuyama, M.; Iwata, K.; Kakehi, T.; Nakagawa, T.; Sango, K.; Shirai, Y.; Yokoyama, T.; Kaneko, S.; Saito, N.; Yabe-Nishimura, C. Reactive oxygen species derived from NOX1/NADPH oxidase enhance inflammatory pain. J. Neurosci., 2008, 28, 9486-9494.
18. Dietrich, J.B.; Mangeol, A.; Revel, M.O.; Burgun, C.; Aunis, D.; Zwiller, J. Acute or repeated cocaine administration generates reactive oxygen species and induces antioxidant enzyme activity in dopaminergic rat brain structures. Neuropharmacology, 2005, 48, 965-974.
19. Spiteller, G. Are changes of the cell membrane structure causally involved in the aging process? Ann. N. Y. Acad. Sci., 2002, 959, 30-44.
20. Pamplona, R.; Costantini, D. Molecular and structural antioxidant defenses against oxidative stress in animals. Am. J. Physiol. Regul. Integr. Comp. Physiol., 2011, 301, R843-R863.
21. Schrader, M.; Fahimi, H.D. Peroxisomes and oxidative stress. Biochim. Biophys. Acta, 2006, 1763, 1755-1766.
22. Dröge, W. Free radicals in the physiological control of cell function. Physiol. Rev., 2002, 82, 47-95.
23. Halliwell, B.; Gutteridge, J. Free Radicals in Biology and Medicine. Oxford University Press, 2007.
24. Janes, K.; Neumann, W.L.; Salvemini, D. Anti-superoxide and anti-peroxynitrite strategies in pain suppression. Biochim. Biophys. Acta, 2012, 1822, 815-821.
25. Baron, C.P.; Berner, L.; Skibsted, L.H.; Refsgaard, H.F. Evaluation of activity of selected antioxidants on proteins in solution and in emulsions. Free Radical Research, 2005, 39, 777-785.
26. Burton, G.J.; Jauniaux, E. Oxidative stress. Best Pract. Res. Clin. Obstet. Gynaecol., 2011, 25, 287-299.
27. Repetto, M.G.; Ossani, G.; Monserrat, A.J.; Boveris, A. Oxidative damage: the biochemical mechanism of cellular injury and necrosis in choline deficiency. Exp. Mol. Pathol., 2010, 88, 143-149.
28. Munhoz, C.D.; García-Bueno, B.; Madrigal, J.L.; Lepsch, L.B.; Scavone, C.; Leza, J.C. Stress-induced neuroinflammation: mechanisms and new pharmacological targets. Braz. J. Med. Biol. Res., 2008, 41, 1037-1046.
29. Okado-Matsumoto, A.; Fridovich, I. Subcellular distribution of superoxide dismutases (SOD) in rat liver. J. Biol. Chem., 2001, 276, 38388-38393.
30. Berk, M.; Nag, F.; Dean, O.; Dodd, S.; Bush, A.I. Glutathione: a novel treatment target in psychiatry. Trends Pharmacol. Sci., 2008, 29, 346-351.
31. Harman, D. Free radical theory of aging: An update: Increasing the functional life span. Ann. N. Y. Acad. Sci., 2006, 1067, 10-21.
32. Al-Gubory, K.H.; Fowler, P.A.; Garrel, C. The roles of cellular reactive oxygen species, oxidative stress and antioxidants in pregnancy outcomes. Int. J. Biochem. Cell. Biol., 2010, 42, 1634-1650.
33. Lien, A.P.H.; Hua, H.; Chuong, P.H. Free radicals, antioxidants in disease and health. Int. J. Biomed. Sci., 2008, 4, 89-96.
34. Baron, R.; Freynhagen, R.; Tölle, T.R.; Cloutier, C.; Leon, T.; Murphy, T.K.; et al. The efficacy and safety of pregabalin in the treatment of neuropathic pain associated with chronic lumbosacral radiculopathy. Pain, 2010, 150, 420-427.
35. Brunton, L.L.; Lazo, J.S.; Parker, K.L.; Murri, N.; Blumenthal, D.K. Goodman & Gilman's the pharmacological basis of therapeutics. McGraw Hill, New York, NY, 2007.
36. Eisenberg, E.; River, Y.; Shifrin, A.; Krivoy, N. Antiepileptic drugs in the treatment of neuropathic pain. Drugs, 2007, 67, 1265-1289.
37. Finnerup, N.B.; Otto, M.; McQuay, H.J.; Jensen, T.S.; Sindrup, S.H. Algorithm for neuropathic pain treatment: An evidence based proposal. Pain, 2005, 118, 289-305.
38. Lopes da Silva, F.; Post, R.M. Evaluation and prediction of effects of antiepileptic drugs in a variety of other CNS disorders. Epilepsy Res., 2002, 50, 191-193.
39. McGivern, J.G.; McDonough, S.I. Voltage-gated calcium channels as targets for the treatment of chronic pain. Curr. Drug Targets CNS Neurol. Disord., 2004, 3, 457-478.
40. Trushina, E.; McMurray, C.T. Oxidative stress and mitochondrial dysfunction in neurodegenerative diseases. Neuroscience, 2007, 145, 1233-1248.
41. Reynolds, A.; Laurie, C; Mosley, R.L.; Gendelman, H.E. Oxidative stress and the pathogenesis of neurodegenerative disorders. Int. Rev. Neurobiol, 2007, 82, 297-325.
42. Uttara, B.; Singh, A.V.; Zamboni, P.; Mahajan, R.T. Oxidative stress and neurodegenerative diseases: a review of upstream and downstream antioxidant therapeutic options. Curr. Neuropharmacol, 2009, 7, 65-74.
43. Reuter, S.; Gupta, S.C.; Chaturvedi, M.M.; Aggarwal, B.B. Oxidative stress, inflammation, and cancer: how are they linked? Free Radic. Biol. Med., 2010, 49, 1603-1616.
44. Barton, M.; Minotti, R.; Haas, E. Inflammation and atherosclerosis. Circ. Res., 2007, 101, 750-751.
45. Ambriz-Tututi, M.; Rocha-Gonzalez, H.I.; Cruz, S.L.; Granados-Soto, V. Melatonin: a hormone that modulates pain. Life Sci., 2009, 84, 489-498.
46. Kussmaul, L.; Hirst, J. The mechanism of superoxide production by NADH: ubiquinone oxidoreductase (Complex I) from bovine heart mitochondria. Proc. Natl. Acad. Sci., 2006, 103, 7607-7612.
47. Ghaisas, M.M.; Dandawate, P.R.; Zawar, S.A.; Ahire, Y.S.; Gandhi, S.P. Antioxidant antinociceptive and anti-inflammatory activities of atorvastatin and rosuvastatin in various experimental models. Inflammopharmacology, 2010, 18, 169-177.
48. Srinivasan, V.; Pandi-Perumal, S.R.; Spence, D.W.; Moscovitch, A.; Trakht, I.; Brown, G.M.; Cardinali, D.P. Potential use of melatonergic drugs in analgesia: mechanisms of action. Brain Res. Bull, 2010, 81, 362-371.
49. Salat, K.; Moniczewski, A.; Salat, R; Janaszek, M.; Filipek, B.; Malawska, B.; Wieckowski, K. Analgesic, anticonvulsant and antioxidant activity of 3-[4-(3-trifluoromethylphenyl)-piperazin-1-yl]-dihydrofuran-2-one dihydrochloride in mice. Pharmacol. Biochem. Behav., 2012, 101, 138-147.
50. Hastings, T.G. Enzymatic oxidation of dopamine: the role of prostaglandin H synthase. J. Neurochem., 1995, 64, 919-924.
51. Burak-Cimen, M.Y.; Cimen, O.B.; Eskandari, G.; Sahin, G.; Erdogan, C; Atik, U. In vivo effects of meloxicam, celecoxib, and ibuprofen on free radical metabolism in human erythrocytes. Drug Chem. Toxicol, 2003, 26, 169-176.
52. Costa, D.; Gomes, A.; Lima, J.L.; Fernandes, E. Singlet oxygen scavenging activity of non-steroidal anti-inflammatory drugs. Redox Rep., 2008, 13, 153-160.
53. Koncic, M.Z.; Rajic, Z.; Petric, N.; Zorc, B. Antioxidant activity of NSAID hydroxamic acids. Acta Pharm., 2009, 59, 235-242.
54. Orhan, H.; Sahin, G. In vitro effects of NSAIDS and paracetamol on oxidative stress-related parameters of human erythrocytes. Exp. Toxicol. Pathol, 2001, 53, 133-140.
55. Sondhi, S.M.; Singhal, N.; Johar, M.; Reddy, B.S.; Lown, J.W. Heterocyclic compounds as inflammation inhibitors. Curr. Med. Chem., 2002, 9, 1045-1074.
56. Fernandes, E.; Costa, D.; Toste, S.A.; Lima, J.L.; Reis, S. In vitro scavenging activity for reactive oxygen and nitrogen species by nonsteroidal anti-inflammatory indole, pyrrole, and oxazole derivative drugs. Free Radic. Biol. Med., 2004, 37, 1895-1905.
57. Halliwell, B.; Hoult, J.R; Blake, D.R. Oxidants, inflammation, and anti-inflammatory drugs. FASEB J., 1988, 2, 2867-2873.
58. Kopff, M.; Kopff, A.; Kowalczyk, E. The effect of nonsteroidal anti-inflammatory drugs on oxidative/antioxidative balance. Pol. Merkur. Lekarski, 2007, 23, 184-187. (in Polish).
59. Galati, G.; Tafazoli, S.; Sabzevari, O.; Chan, T.S.; O'Brien, P.J. Idiosyncratic NSAID drug induced oxidative stress. Chem. Biol. Interact, 2002, 142, 25-41.
60. Dengiz, G.O.; Odabasoglu, F.; Halici, Z.; Cadirci, E.; Suleyman, H. Gastroprotective and antioxidant effects of montelukast on indomethacin-induced gastric ulcer in rats. J. Pharmacol. Sci., 2007, 105, 94-102.
61. Leone, S.; Ottani, A.; Bertolini, A. Dual acting anti-inflammatory drugs. Curr. Top. Med. Chem., 2007, 7, 265-275.
62. Rao, P.; Knaus, E.E. Evolution of nonsteroidal anti-inflammatory drugs (NSAIDs): cyclooxygenase (COX) inhibition and beyond. J. Pharm. Pharm. Sci., 2008, 11, 81s-110s.
63. Grundman, M.; Delaney, P. Antioxidant strategies for Alzheimer's disease. Proc Nat. Soc., 2002, 61, 191-202.
64. Hsieh, Y.C.; Mounsey, R.B.; Teismann, P. MPP(+)-induced toxicity in the presence of dopamine is mediated by COX-2 through oxidative stress. Naunyn Schmiedebergs Arch. Pharmacol., 2011, 384, 157-167.
65. Kumar, A.; Kumari, B.; Kumar, P. Protective effects of selective and non-selective cyclooxygenase inhibitors in an animal model of chronic stress. Neurosci. Bull., 2010, 26, 17-27.
66. Hastings, T.G. Enzymatic oxidation of dopamine: the role of prostaglandin H synthase. J. Neurochem., 1995, 64, 919-924.
67. Van Antwerpen, P.; Nève, J. In vitro comparative assessment of the scavenging activity against three reactive oxygen species of non-steroidal anti-inflammatory drugs from the oxicam and sulfoanilide families. Eur. J. Pharmacol., 2004, 496, 55-61.
68. Costa, D.; Gomes, A.; Reis, S.; Lima, J.L.; Fernandes, E. Hydrogen peroxide scavenging activity by non-steroidal anti-inflammatory drugs. Life Sci., 2005, 76, 2841-2848.
69. Graf, P.; Glatt, M.; Brune, K. Acidic nonsteroid anti-inflammatory drugs accumulating in inflamed tissue. Experientia, 1975, 31, 951-953.
70. Costa, D.; Gomes, A.; Lima, J.L.; Fernandes, E. Singlet oxygen scavenging activity of non-steroidal anti-inflammatory drugs. Redox Rep., 2008, 13, 153-160.
71. Stetinová, V.; Smetanová, L.; Grossmann, V.; Anzenbacher, P. In vitro and in vivo assessment of the antioxidant activity of melatonin and related indole derivatives. Gen. Physiol. Biophys., 2002, 21, 153-162.
72. Mouithys-Mickalad, A.M.; Zheng, S.X.; Deby-Dupont, G.P.; Deby, C.M.; Lamy, M.M.; Reginster, J.Y.; Henrotin, Y.E. In vitro study of the antioxidant properties of non-steroidal anti-inflammatory drugs by chemiluminescence and electron spin resonance (ESR). Free Radic. Res., 2000, 33, 607-621.
73. Oyanagui, Y. Inhibition of superoxide anion production in macrophages by anti-inflammatory drugs. Biochem. Pharmacol., 1976, 25, 1473-1480.
74. Parij, N.; Nagy, A.M.; Fondu, P.; Nève, J. Effects of non-steroidal anti-inflammatory drugs on the luminol and lucigenin amplified chemiluminescence of human neutrophils. Eur. J. Pharmacol., 1998, 352, 299-305.
75. Hiller, K.O.; Hodd, P.L.; Willson, R.L. Antiinflammatory drugs: protection of a bacterial virus as an in vitro biological measure of free radical activity. Chem. Biol. Interact., 1983, 47, 293-305.
76. Aruoma, O.I.; Halliwell, B. The iron-binding and hydroxyl radical scavenging action of anti-inflammatory drugs. Xenobiotica, 1988, 18, 459-470.
77. Prasad, K.; Laxdal, V.A. Hydroxyl radical-scavenging property of indomethacin. Mol. Cell. Biochem., 1994, 136, 139-144.
78. Parij, N.; Nagy, A.M.; Neve, J. Linear and non-linear competition plots in the deoxyribose assay for determination of rate constants for reaction of nonsteroidal antiinflammatory drugs with hydroxyl radicals. Free Radic. Res., 1995, 23, 571-579.
79. Ikeda, Y.; Matsumoto, K.; Dohi, K.; Jimbo, H.; Sasaki, K.; Satoh, K. Direct superoxide scavenging activity of nonsteroidal anti-inflammatory drugs: determination by electron spin resonance using the spin trap method. Headache, 2001, 41, 138-141.
80. Kirkova, M.; Kassabova, T.; Russanov, E. In vivo effects of indomethacin-I. Activity of antioxidant enzymes and lipid peroxidation. Gen. Pharmacol., 1992, 23, 503-507.
81. Maffei-Facino, R.M.; Carini, M.; Saibene L. Scavenging of free radicals by tenoxicam: a participating mechanism in the antirheumatic/anti-inflammatory efficacy of the drug. Arch. Pharm. (Weinheim), 1996, 329, 457-463.
82. Nève, J.; Parij, N.; Moguilevsky, N. Inhibition of the myeloperoxidase chlorinating activity by non-steroidal anti-inflammatory drugs investigated with a human recombinant enzyme. Eur. J. Pharmacol., 2001, 417, 37-43.
83. Costa, D.; Vieira, A.; Fernandes, E. Dipyrone and aminopyrine are effective scavengers of reactive nitrogen species. Redox Rep., 2006, 11, 136-142.
84. Stolc, S. Indole derivatives as neuroprotectants. Life Sci., 1999, 65, 1943-1950.
85. Halliwell, B.; Hoult, J.R.; Blake, D.R. Oxidants, inflammation, and anti-inflammatory drugs. FASEB J., 1988, 2, 2867-2873.
86. Villegas, I.; Martín, M.J.; La Casa, C; Motilva, V.; Alarcón de la Lastra, C. Effects of meloxicam on oxygen radical generation in rat gastric mucosa. Inflamm. Res., 2000, 49, 361-366.
87. Villegas, I.; Martín, M.J.; La Casa, C; Motilva, V.; De La Lastra, C.A. Effects of oxicam inhibitors of cyclooxygenase on oxidative stress generation in rat gastric mucosa. A comparative study. Free Radic. Res., 2002, 36, 769-777.
88. Agha, A.M.; El-Khatib, A.S.; Al-Zuhair, H. Modulation of oxidant status by meloxicam in experimentally induced arthritis. Pharmacol. Res., 1999, 40, 385-392.
89. Gurocak, S.; Ure, I.; Cumaoglu, A.; Gonul, I.I.; Sen, I.; Tan, O.; Aricioglu, A.; Bozkirli, I. Renal tissue damage after experimental pyelonephritis: role of antioxidants and selective cyclooxygenase-2 inhibitors. Urology, 2010, 76, 508.e1-508.e5.
90. Naziroglu, M.; Uguz, A.C.; Gokçimen, A.; Bülbül, M.; Karatopuk, D.U.; Türker, Y.; Cerçi, C. Tenoxicam modulates antioxidant redox system and lipid peroxidation in rat brain. Neurochem. Res., 2008, 33, 1832-1837.
91. Ezberci, F.; Bulbuloglu, E.; Ciragil, P.; Gul, M.; Kurutas, E.B.; Bozkurt, S.; Kale, I.T. Intraperitoneal tenoxicam to prevent abdominal adhesion formation in a rat peritonitis model. Surg. Today, 2006, 36, 361-366.
92. Weber, V.; Coudert, P.; Duroux, E.; Leal, F.; Couquelet, J.; Madesclaire, M. Synthesis and in vitro studies of pyrone derivatives as scavengers of active oxygen species. Arzneimittelforschung, 2001, 51, 877-884.
93. Dursun, H.; Bilici, M.; Albayrak, F.; Ozturk, C; Saglam, M.B.; Alp, H.H.; Suleyman, H. Antiulcer activity of fluvoxamine in rats and its effect on oxidant and antioxidant parameters in stomach tissue. BMC Gastroenterol, 2009, 9, 36.
94. Villegas, I.; Alarcón de la Lastra, C; La Casa, C; Motilva, V.; Martín, M.J. Effects of food intake and oxidative stress on intestinal lesions caused by meloxicam and piroxicam in rats. Eur. J. Pharmacol, 2001, 414, 79-86.
95. Tanaka, J.; Yuda, Y. Lipid peroxidation in gastric mucosal lesions induced by indomethacin in rat. Biol. Pharm. Bull, 1996, 19, 716-720.
96. Somasundaram, S.; Sigthorsson, G.; Simpson, R.J.; Watts, J.; Jacob, M.; Tavares, I.A.; Rafi, S.; Roseth, A.; Foster, R; Price, A.B.; Wrigglesworth, J.M.; Bjarnason, I. Uncoupling of intestinal mitochondrial oxidative phosphorylation and inhibition of cyclooxygenase re required for the development of NSAID-enteropathy in the rat. Aliment. Pharmacol. Ther., 2000, 14, 639-650.
97. Costa, D.; Marques, A.P.; Reis, R.L.; Lima, J.L.; Fernandes, E. Inhibition of human neutrophil oxidative burst by pyrazolone derivatives. Free Radic. Biol. Med., 2006, 40, 632-640.
98. Mannelli, P.; Patkar, A.; Rozen, S.; Matson, W.; Krishnan, R.; Kaddurah-Daouk, R. Opioid use affects antioxidant activity and purine metabolism: preliminary results. Hum. Psychopharmacol, 2009, 24, 666-675.
99. Pereska, Z.; Dejanova, B.; Bozinovska, C; Petkovska, L. Prooxidative/antioxidative homeostasis in heroin addiction and detoxification. Bratisl. Lek. Listy, 2007, 108, 393-398.
100. Gülçin, I.; Beydemir, S.; Alici, H.A.; Elmasta, M.; Büyükokuroglu, M.E. In vitro antioxidant properties of morphine. Pharmacol. Res., 2004, 49, 59-66.
101. Bosshart, H. Morphine and cancer progression: hydrogen peroxide points to need for more research. J. Opioid Manag., 2011, 7, 93-96.
102. Di Bello, M.G.; Masini, E.; Ioannides, C; Fomusi-Ndisang, J.; Raspanti, S.; Bani-Sacchi, T.; Mannaioni, P.F. Histamine release from rat mast cells induced by the metabolic activation of drugs of abuse into free radicals. Inflamm. Res., 1998, 47, 122-130.
103. Bhat, R.S.; Bhaskaran, M.; Mongia, A.; Hitosugi, N.; Singhal, P.C. Morphine-induced macrophage apoptosis: oxidative stress and strategies for modulation. J. Leukoc. Biol, 2004, 75, 1131-1138.
104. Abdel-Zaher, A.O.; Abdel-Rahman, M.S.; ELwasei, F.M. Blockade of nitric oxide overproduction and oxidative stress by Nigella sativa oil attenuates morphine-induced tolerance and dependence in mice. Neurochem. Res., 2010, 35, 1557-1565.
105. Zhang, Y.T.; Zheng, Q.S.; Pan, J.; Zheng, R.L. Oxidative damage of biomolecules in mouse liver induced by morphine and protected by antioxidants. Basic Clin. Pharmacol. Toxicol, 2004, 95, 53-58.
106. Doyle, T.; Bryant, L.; Batinic-Haberle, I.; Little, J.; Cuzzocrea, S.; Masini, E.; Spasojevic, I.; Salvemini, D. Supraspinal inactivation of mitochondrial superoxide dismutase is a source of peroxynitrite in the development of morphine antinociceptive tolerance. Neuroscience, 2009, 164, 702-710.
107. Calderón-Guzmán, D.; Osnaya-Brizuela, N.; García-Alvarez, R.; Hernández-García, E.; Juárez-Olguín, H. Oxidative stress induced by morphine in brain of rats fed with a protein deficient diet. Hum. Exp. Toxicol, 2009, 28, 577-582.
108. Goudas, L.C.; Carr, D.B.; Maszczynska, I.; Marchand, J.E.; Wurm, W.H.; Greenblatt, DJ.; Kream, R.M. Differential effect of central versus parenteral administration of morphine sulfate on regional concentrations of reduced glutathione in rat brain. Pharmacology, 1997, 54, 92-97.
109. Singhal, P.C.; Pamarthi, M.; Shah, R.; Chandra, D.; Gibbons, N. Morphine stimulates superoxide formation by glomerular mesangial cells. Inflammation, 1994, 18, 293-299.
110. Patel, J.; Manjappa, N.; Bhat, R.; Mehrotra, P.; Bhaskaran, M.; Singhal, P.C. Role of oxidative stress and heme oxygenase activity in morphine-induced glomerular epithelial cell growth. Am. J. Physiol. Renal Physiol, 2003, 285, F861-F869.
111. Enrico, P.; Esposito, G.; Mura, M.A.; Migheli, R.; Serra, P.A.; Desole, M.S.; Miele, E.; De Natale, G.; Miele, M. Effects of allopurinol on striatal dopamine, ascorbate and uric acid during an acute morphine challenge: ex vivo and in vivo studies. Pharmacol. Res., 1997, 35, 577-585.
112. Pérez-Casanova, A.; Husain, K.; Noel, R.J. Jr.; Rivera-Amill, V.; Kumar, A. Interaction of SIV/SHIV infection and morphine on plasma oxidant/antioxidant balance in macaque. Mol Cell. Biochem., 2008, 308, 169-175.
113. Atici, S.; Cinel, I.; Cinel, L.; Doruk, N.; Eskandari, G.; Oral, U. Liver and kidney toxicity in chronic use of opioids: an experimental long term treatment model. J. Biosci., 2005, 30, 245-252.
114. William, S.; Sekar, N.; Subramanian, S.; Govindasamy, S. Toxic effect of morphine and the antagonistic role of naloxone on isolated rat hepatocytes. Biochem. Int., 1991, 23, 1071-1077.
115. Popovic, M.; Janicijevic-Hudomal, S.; Kaurinovic, B.; Rasic, J; Trivic, S.; Vojnovic, M. Antioxidant effects of some drugs on immobilization stress combined with cold restraint stress. Molecules, 2009, 14, 4505-4516.
116. Kang, M.Y.; Tsuchiya, M.; Packer, L.; Manabe, M. In vitro study on antioxidant potential of various drugs used in the perioperative period. Acta Anaesthesiol Scand., 1998, 42, 4-12.
117. Bhatti, F.; Mankhey, R.W.; Asico, L.; Quinn, M.T.; Welch, W.J.; Maric, C. Mechanisms of antioxidant and pro-oxidant effects of alpha-lipoic acid in the diabetic and nondiabetic kidney. Kidney Int., 2005, 67, 1371-1380.
118. Duby, J.J.; Campbell, R.K.; Setter, S.M.; White, J.R.; Rasmussen, K.A. Diabetic neuropathy: an intensive review. Am. J. Health Syst. Pharm., 2004, 61, 160-173.
119. Mijnhout, G.S.; Alkhalaf, A.; Kleefstra, N.; Bilo, H.J. Alpha lipoic acid: a new treatment for neuropathic pain in patients with diabetes? Neth. J. Med., 2010, 68, 158-162.
120. Vanotti, A.; Osio, M.; Mailland, E.; Nascimbene, C; Capiluppi, E.; Mariani, C. Overview on pathophysiology and newer approaches to treatment of peripheral neuropathies. CNS Drugs, 2007, 21(Suppl 1), 3-12.
121. Kim, H.K.; Park, S.K.; Zhou, J.L.; Taglialatela, G.; Chung, K.; Coggeshall, R.E.; Chung, J.M. Reactive oxygen species (ROS) play an important role in a rat model of neuropathic pain. Pain, 2004, 111, 116-124.
122. Yowtak, J.; Lee, K.Y.; Kim, H.Y.; Wang, J.; Kim, H.K.; Chung, K.; Chung, J.M. Reactive oxygen species contribute to neuropathic pain by reducing spinal GABA release. Pain, 2011, 152, 844-852.
123. Vircheva, S.; Nenkova, G.; Georgieva, A.; Alexandrova, A.; Tzvetanova, E.; Mateeva, P.; Zamfirova, R.; Kirkova, M. Effects of desipramine on the antioxidant status in rat tissues at carrageenan-induced paw inflammation. Cell. Biochem. Funct., 2011, 30, 18-23.
124. Pereira, P.; Gianesini, J.; da Silva Barbosa, C; Cassol, G.F.; Von Borowski, R.G.; Kahl, V.F.; Cappelari, S.E.; Picada, J.N. Neurobehavioral and genotoxic parameters of duloxetine in mice using the inhibitory avoidance task and comet assay as experimental models. Pharmacol. Res., 2009, 59, 57-61.
125. Kirkova, M.; Tzvetanova, E.; Vircheva, S.; Zamfirova, R.; Grygier, B.; Kubera, M. Antioxidant activity of fluoxetine: studies in mice melanoma model. Cell. Biochem. Funct., 2010, 28, 497-502.
126. Chung, Y.C.; Kim, S.R.; Jin, B.K. Paroxetine prevents loss of nigrostriatal dopaminergic neurons by inhibiting brain inflammation and oxidative stress in an experimental model of Parkinson's disease. J. Immunol, 2010, 185, 1230-1237.
127. Eren, I.; Naziroglu, M.; Demirdaş, A. Protective effects of lamotrigine, aripiprazole and escitalopram on depression-induced oxidative stress in rat brain. Neurochem. Res., 2007, 32, 1188-1195.
128. Yoshikawa, Y.; Hosomi, H.; Fukami, T.; Nakajima, M.; Yokoi, T. Establishment of knockdown of superoxide dismutase 2 and expression of CYP3A4 cell system to evaluate drug-induced cytotoxicity. Toxicol. In Vitro., 2009, 23, 1179-1187.
129. Morgado, C; Pereira-Terra, P.; Cruz, CD.; Tavares, I. Minocycline completely reverses mechanical hyperalgesia in diabetic rats through microglia-induced changes in the expression of the potassium chloride co-transporter 2 (KCC2) at the spinal cord. Diabetes Obes. Metab., 2011, 13, 150-159.
130. Tanabe, M.; Sakaue, A.; Takasu, K.; Honda, M.; Ono, H. Centrally mediated antihyperalgesic and antiallodynic effects of zonisamide following partial nerve injury in the mouse. Naunyn Schmiedebergs Arch. Pharmacol, 2005, 372, 107-114.
131. Cengiz, M.; Yüksel, A.; Seven, M. The effects of carbamazepine and valproic acid on the erythrocyte glutathione, glutathione peroxidase, superoxide dismutase and serum lipid peroxidation in epileptic children. Pharmacol. Res., 2000, 41, 423-425.
132. Stanton, P.K.; Moskal, J.R. Diphenylhydantoin protects against hypoxia-induced impairment of hippocampal synaptic transmission. Brain Res., 1991, 546, 351-354.
133. Kaptanoglu, E.; Solaroglu, I.; Surucu, H.S.; Akbiyik, F.; Beskonakli, E. Blockade of sodium channels by phenytoin protects ultrastructure and attenuates lipid peroxidation in experimental spinal cord injury. Acta Neurochir. (Wien), 2005, 147, 405-412.
134. Solowiej, E.; Sobaniec, W. The effect of antiepileptic drug therapy on antioxidant enzyme activity and serum lipid peroxidation in young patients with epilepsy. Neurol. Neurochir. Pol, 2003, 37, 991-1003. (in Polish).
135. Varoglu, A.O.; Yildirim, A.; Aygul, R.; Gundogdu, O.L.; Sahin, Y.N. Effects of valproate, carbamazepine, and levetiracetam on the antioxidant and oxidant systems in epileptic patients and their clinical importance. Clin. Neuropharmacol, 2010, 33, 155-157.
136. Arora, T.; Mehta, A.K.; Sharma, K.K.; Mediratta, P.K.; Banerjee, B.D.; Garg, G.R.; Sharma, A.K. Effect of carbamazepine and lamotrigine on cognitive function and oxidative stress in brain during chemical epileptogenesis in rats. Basic Clin. Pharmacol, Toxicol, 2010, 106, 372-377.
137. Yüksel, A.; Cengiz, M.; Seven, M.; Ulutin, T. Erythrocyte glutathione, glutathione peroxidase, superoxide dismutase and serum lipid peroxidation in epileptic children with valproate and carbamazepine monotherapy. J. Basic Clin. Physiol. Pharmacol, 2000, 11, 73-81.
138. Li, Z.H.; Li, P.; Randak, T. Effect of a human pharmaceutical carbamazepine on antioxidant responses in brain of a model teleost in vitro: an efficient approach to biomonitoring. J. Appl. Toxicol, 2010, 30, 644-648.
139. Li, Z.H.; Zlabek, V.; Velisek, J.; Grabic, R.; Machova, J.; Randak, T. Modulation of antioxidant defence system in brain of rainbow trout (Oncorhynchus mykiss) after chronic carbamazepine treatment. Comp. Biochem. Physiol. C Toxicol. Pharmacol, 2010, 151, 137-141.
140. Pavone, A.; Cardile, V. An in vitro study of new antiepileptic drugs and astrocytes. Epilepsia, 2003, 44(Suppl 10), 34-39.
141. Cardile, V.; Pavone, A.; Renis, M.; Russo, A.; Perciavalle, V. Biological effects of tiagabine on primary cortical astrocyte cultures of rat. Neurosci. Lett, 2000, 288, 49-52.
142. Bolayir, E.; Celik, K.; Tas, A.; Topaktas, S.; Bakir, S. The effects of oxcarbazepine on oxidative stress in epileptic patients. Methods Find. Exp. Clin. Pharmacol, 2004, 26, 345-348.
143. Tufan, K.; Oztanir, N.; Ofluoglu, E.; Ozogul, C; Uzum, N.; Dursun, A.; Pasaoglu, H.; Pasaoglu, A. Ultrastructure protection and attenuation of lipid peroxidation after blockade of presynaptic release of glutamate by lamotrigine in experimental spinal cord injury. Neurosurg. Focus, 2008, 25, E6.
144. Bakare, A.; Shao, L.; Cui, J.; Young, L.T.; Wang, J.F. Mood stabilizing drugs lamotrigine and olanzapine increase expression and activity of glutathione S-transferase in primary cultured rat cerebral cortical cells. Neurosci. Lett., 2009, 455, 70-73.
145. Agarwal, N.B.; Agarwal, N.K.; Mediratta, P.K.; Sharma, K.K. Effect of lamotrigine, oxcarbazepine and topiramate on cognitive functions and oxidative stress in PTZ-kindled mice. Seizure, 2011, 20, 257-262.
146. Farooq, M.U.; Moore, P.W.; Bhatt, A.; Aburashed, R.; Kassab, M.Y. Therapeutic role of zonisamide in neuropsychiatric disorders. Mini Rev. Med. Chem., 2008, 8, 968-975.
147. Mori, A.; Noda, Y.; Packer, L. The anticonvulsant zonisamide scavenges free radicals. Epilepsy Res., 1998, 30, 153-158.
148. Sonsalla, P.K.; Wong, L.Y.; Winnik, B.; Buckley, B. The antiepileptic drug zonisamide inhibits MAO-B and attenuates MPTP toxicity in mice: clinical relevance. Exp. Neurol., 2010, 221, 329-334.
149. Lu, W.; Uetrecht, J.P. Peroxidase-mediated bioactivation of hydroxylated metabolites of carbamazepine and phenytoin. Drug Metab. Dispos., 2008, 36, 1624-1636.
150. Santos, N.A.; Medina, W.S.; Martins, N.M.; Rodrigues, M.A.; Curti, C; Santos, A.C. Involvement of oxidative stress in the hepatotoxicity induced by aromatic antiepileptic drugs. Toxicol. In Vitro, 2008, 22, 1820-1824.
151. Ikeda, Y.; Jimbo, H.; Shimazu, M.; Satoh, K. Sumatriptan scavenges superoxide, hydroxyl, and nitric oxide radicals: in vitro electron spin resonance study. Headache, 2002, 42, 888-892.
152. Cakatay, U. Pro-oxidant actions of alpha-lipoic acid and dihydrolipoic acid. Med. Hypotheses, 2006, 66, 110-117.
153. Assem, E.S.; Mann, S.; Wan, B.Y.; Marson, CM. Effect of antioxidants on airway smooth muscle contraction: action of lipoic acid and some of its novel derivatives on guinea pig tracheal smooth muscle. Inflamm. Res., 2010, 59(Suppl 2), S235-S237.
154. Gora-ca, A.; Huk-Kolega, H.; Piechota, A.; Kleniewska, P.; Ciejka, E.; Skibska, B. Lipoic acid - biological activity and therapeutic potential. Pharmacol. Rep., 2011, 63, 849-858.
155. Jameel, N.M.; Shekhar, M.A.; Vishwanath, B.S. Alpha-lipoic acid: an inhibitor of secretory phospholipase A2 with anti-inflammatory activity. Life Sci., 2006, 80, 146-153.
156. Morgado, C; Pereira-Terra, P.; Tavares, I. a-Lipoic acid normalizes nociceptive neuronal activity at the spinal cord of diabetic rats. Diabetes Obes. Metab., 2011, 13, 736-741.
157. Tastekin, N.; Aydogdu, N.; Dokmeci, D.; Usta, U.; Birtane, M.; Erbas, H.; Ture, M. Protective effects of L-carnitine and alpha-lipoic acid in rats with adjuvant arthritis. Pharmacol. Res., 2007, 56, 303-310.
158. Ying, Z.; Kampfrath, T.; Sun, Q.; Parthasarathy, S.; Rajagopalan, S. Evidence that a-lipoic acid inhibits NF-kB activation independent of its antioxidant function. Inflamm. Res., 2011, 60, 219-225.
159. Kumaran, S.; Savitha, S.; Anusuya Devi, M.; Panneerselvam, C. Lcarnitine and DL-alpha-lipoic acid reverse the age-related deficit in glutathione redox state in skeletal muscle and heart tissues. Mech. Ageing Dev., 2004, 125, 507-512.
160. Melhem, M.F.; Craven, P.A.; Liachenko, J.; De Rubertis, F.R. Alpha-lipoic acid attenuates hyperglycemia and prevents glomerular mesangial matrix expansion in diabetes. J. Am. Soc. Nephrol, 2002, 13, 108-116.
161. Moraes, T.B.; Zanin, F.; da Rosa, A.; de Oliveira, A.; Coelho, J.; Petrillo, F.; Wajner, M.; Dutra-Filho, CS. Lipoic acid prevents oxidative stress in vitro and in vivo by an acute hyperphenylalaninemia chemically-induced in rat brain. J. Neurol. Sci., 2010, 292, 89-95.
162. Mottley, C; Mason, R.P. Sulfur-centered radical formation from the antioxidant dihydrolipoic acid. J. Biol. Chem., 2001, 276, 42677-42683.
163. Beltramo, M. Cannabinoid type 2 receptor as a target for chronic -pain. Mini Rev. Med. Chem., 2009, 9, 11-25.
164. Duarte, CD.; Tributino, J.L.; Lacerda, D.I.; Martins, M.V.; Alexandre-Moreira, M.S.; Dutra, F.; Bechara, E.J.; De-Paula, F.S.; Goulart, M.O.; Ferreira, J.; Calixto, J.B.; Nunes, M.P.; Bertho, A.L.; Miranda, A.L.; Barreiro, E.J.; Fraga, C.A. Synthesis, pharmacological evaluation and electrochemical studies of novel 6-nitro-3,4-methylenedioxyphenyl-N acylhydrazone derivatives: Discovery of LASSBio-881, a new ligand of cannabinoid receptors. Bioorg. Med. Chem., 2007, 15, 2421-2433.
165. Salat, K.; Filipek, B.; Wieckowski, K.; Malawska, B. Analgesic activity of 3-mono-substituted derivatives of dihydrofuran-2-one in experimental rodent models of pain. Pharmacol. Rep., 2009, 61, 807-818.
166. Salat, K.; Librowski, T.; Moniczewski, A.; Stanisz-Wallis, K.; Wieckowski, K.; Malawska, B. Analgesic, antioedematous and antioxidant activity of y-butyrolactone derivatives in rodents. Behav. Pharmacol, 2012, 23, 407-416. doi: 10.1097/ FBP.0b013e3283566042.
167. Guay, J.; Bateman, K.; Gordon, R.; Mancini, J.; Riendeau, D. Carrageenan-induced paw edema in rat elicits a predominant prostaglandin E2 (PGE2) response in the central nervous system associated with the induction of microsomal PGE2 synthase-1. J. Biol. Chem., 2004, 279, 24866-24872.
168. Wang, T.; Fu, F.; Zhang, L.; Han, B.; Zhu, M.; Zhang, X. Effects of escin on acute inflammation and the immune system in mice. Pharmacol. Rep., 2009, 61, 697-704.
169. Di Rosa, M.; Sorrentino, L. The mechanism of the inflammatory effect of carrageenin. Eur. J. Pharmacol, 1968, 4, 340-342.
170. Di Rosa, M.; Giroud, J.P.; Willoughby, D.A. Studies on the mediators of the acute inflammatory response induced in rats in different sites by carrageenan and turpentine. J. Pathol, 1971, 104, 15-29.